Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative
- 28 February 1993
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 16 (2), 111-118
- https://doi.org/10.1016/0732-8893(93)90004-q
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Combination Therapy in Systemic MycosisJournal of Chemotherapy, 1990
- Bacterial vaginosis: Diagnostic and pathogenetic findings during topical clindamycin therapyAmerican Journal of Obstetrics and Gynecology, 1990
- Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Should novobiocin be clinically re-evaluated?Diagnostic Microbiology and Infectious Disease, 1989
- In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticumDiagnostic Microbiology and Infectious Disease, 1989
- Attemps to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rafampin, and bacitracinAmerican Journal of Infection Control, 1988
- Treatment of Small Intestine Bacterial Overgrowth with Rifaximin, a Non-Absorbable RifamycinJournal of International Medical Research, 1988
- Rifaximin, a Rifamycin Derivative for Use in the Treatment of Intestinal Bacterial Infections in Seriously Disabled PatientsJournal of International Medical Research, 1987
- X-ray crystal structure of 4-deoxy-3'-bromopyrido(1',2'-1,2)imidazo(5,4-c)rifamycin S.The Journal of Antibiotics, 1984
- Pharmacokinetics of L/105, a New Rifamycin, in Rats and Dogs, after Oral AdministrationChemotherapy, 1983